Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus

Eman M. Alfadhli, Taif S. Alharbi, Abrar M. Alrotoie, Asia A. Aljohani, Amal S. Qari, Bashaer A. Alsubhi, Aram H. Alsaedi and Alaa A. Aljohani
Saudi Medical Journal January 2024, 45 (1) 86-92; DOI: https://doi.org/10.15537/smj.2024.45.1.2023060
Eman M. Alfadhli
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eman M. Alfadhli
  • For correspondence: [email protected]
Taif S. Alharbi
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abrar M. Alrotoie
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asia A. Aljohani
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amal S. Qari
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bashaer A. Alsubhi
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aram H. Alsaedi
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alaa A. Aljohani
From the Medical College (Alfadhli, Alharbi, Alrotoie, Asia Aljohani, Qari, Alsubhi, Alsaedi), Taibah University, from the Department of Internal Medicine (Alfadhli), King Faisal Specialist Hospital and Research Center, and from the Diabetes Center (Alaa Aljohani), King Salman Bin Abdulaziz Medical City, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    - Frequency of hypoglycemic medications use in type 2 diabetes mellitus group (n=370). DPP4: dipeptidyl peptidase-4 inhibitor, SGLT2I: sodium-glucose cotransporter-2, GLP1-A: glucagon-like peptide-1 agonist, TZD: thiazolidinediones

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    - Timing of breaking the fast.

Tables

  • Figures
    • View popup
    Table 1

    - Baseline characteristics of the whole group and each risk group category (N=466).

    VariablesAll patientsIDF-DAR risk stratificationP-values
    Low risk (n=86)Moderate risk (n=115)High risk (n=265)
    Age (years)49.0±16.953.8±13.148.7±15.547.5±18.30.011
    HbA1c8.7±1.87.6±1.58.8±1.79.0±1.70.000
    e-GFR93.2±30.187.21±26.794.5±26.994.6±32.30.115
    Duration of diabetes (years)11.6±8.27.3±5.510.0±7.913.6±8.30.000
    Type 1 diabetes96 (20.6)2 (2.1)13 (13.5)81 (84.4)0.000
    Type 2 diabetes370 (79.4)84 (22.7)102 (27.6)184 (49.7)0.000

    Values are presented as numbers and precentages (%) or mean ± standard deviation (SD).

    IDF-DAR: International Diabetes Federation-Diabetes and Ramadan International Alliance, HbA1c: hemoglobin A1c, e-GFR: estimated glomerular filtration rate

      • View popup
      Table 2

      - Association between International Diabetes Federation-Diabetes and Ramadan International Alliance risk stratification score and Ramadan fasting in individuals with diabetes (N=466).

      FactorsAll patients (N=466)IDF-DAR risk stratificationP-values
      Low risk (n=86)Moderate risk (n=115)High risk (n=265)
      Fast all days of Ramadan298 (63.9)76 (88.4)81 (70.4)14 (53.2)0.000
      Did not fast the whole month of Ramadan168 (36.1)10 (11.6)34 (29.6)124 (46.8)0.000
      Diabetes related causes for non-fasting106 (22.4)4 (4.7)18 (15.7)84 (31.7)0.000
      Hypoglycemia95 (20.4)4 (4.7)16 (13.9)75 (28.3)0.000
      Hyperglycemia27 (5.8)1 (1.2)4 (3.5)22 (8.3)0.023
      DKA1 (0.2)0 (0.0)0 (0.0)1 (0.4)0.684
      Number of non-fasting days3.01±6.70.63±2.02.03±54.2±80.000
      Admission to the hospital during Ramadan10 (2.1)0 (0.0)0 (0.0)10 (3.8)0.021

      Values are presented as numbers and precentages (%) or mean ± standard deviation.

      IDF-DAR: International Diabetes Federation-Diabetes and Ramadan International Alliance, DKA: diabetic ketoacidosis

        • View popup
        Table 3

        - Binomial logistic regression for the association between non-fasting all days of Ramadan and International Diabetes Federation-Diabetes and Ramadan International Alliance risk stratification score (N=466).

        IDF-DAR risk stratification scoreOdds ratioP-values95% CI
        LowerUpper
        High risk versus moderate risk2.090.0021.313.34
        Moderate risk versus low risk3.190.0031.486.90
        High risk versus low risk6.690.0003.3113.49

        IDF-DAR: International Diabetes Federation - Diabetes and Ramadan Alliance, CI: confidence interval

          • View popup
          Table 4

          - Association between diabetes type and International Diabetes Federation-Diabetes and Ramadan International Alliance risk stratification with fasting Ramadan (N=466).

          FactorsDiabetes typeP-values
          T1DM (n=96)T2DM (n=370)
          Age (years)24.2±8.155.4±11.90.000
          Duration of diabetes (years)11.4±7.311.6±8.30.880
          HbA1c8.8±1.78.6±1.80.211
          IDF-DAR risk stratification
          Low risk2 (2.1)84 (22.7)0.000
          Moderate risk13 (13.5)102 (27.6)
          High risk81 (84.4)18 (49.7)
          Fast all days of Ramadan13 (13.5)285 (77.0)0.000
          Did not fast the whole month of Ramadan83 (86.5)85 (23.0)0.000
          Diabetes related causes for non-fasting59 (61.5)4 (12.7)0.000
          Hypoglycemia54 (56.1)41 (11.1)0.000
          Hyperglycemia18 (18.8)9 (2.4)0.000
          DKA1 (1.0)0 (0.0)0.050
          Admission to the hospital3 (3.1)7 (1.9)0.459
          Breaking the fasting in the first 5 hours of the day2.1±4.40.21±0.60.000
          Breaking the fasting from 5 hours until 10 hours1.02±2.10.84±2.10.600
          Breaking the fasting after more than 10 hours0.75±2.10.67±1.50.757

          Values are presented as numbers and precentages (%) or mean ± standard deviation (SD).

          T1DM: type 1 diabetes mellitus, T2DM: type 2 diabetes mellitus, HbA1c: hemoglobin A1c, IDF-DAR: International Diabetes Federation - Diabetes and Ramadan Alliance, DKA: diabetic ketoacidosis

          PreviousNext
          Back to top

          In this issue

          Saudi Medical Journal: 45 (1)
          Saudi Medical Journal
          Vol. 45, Issue 1
          1 Jan 2024
          • Table of Contents
          • Cover (PDF)
          • Index by author
          Print
          Download PDF
          Email Article

          Thank you for your interest in spreading the word on Saudi Medical Journal.

          NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

          Enter multiple addresses on separate lines or separate them with commas.
          Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus
          (Your Name) has sent you a message from Saudi Medical Journal
          (Your Name) thought you would like to see the Saudi Medical Journal web site.
          Citation Tools
          Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus
          Eman M. Alfadhli, Taif S. Alharbi, Abrar M. Alrotoie, Asia A. Aljohani, Amal S. Qari, Bashaer A. Alsubhi, Aram H. Alsaedi, Alaa A. Aljohani
          Saudi Medical Journal Jan 2024, 45 (1) 86-92; DOI: 10.15537/smj.2024.45.1.2023060

          Citation Manager Formats

          • BibTeX
          • Bookends
          • EasyBib
          • EndNote (tagged)
          • EndNote 8 (xml)
          • Medlars
          • Mendeley
          • Papers
          • RefWorks Tagged
          • Ref Manager
          • RIS
          • Zotero
          Share
          Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus
          Eman M. Alfadhli, Taif S. Alharbi, Abrar M. Alrotoie, Asia A. Aljohani, Amal S. Qari, Bashaer A. Alsubhi, Aram H. Alsaedi, Alaa A. Aljohani
          Saudi Medical Journal Jan 2024, 45 (1) 86-92; DOI: 10.15537/smj.2024.45.1.2023060
          Twitter logo Facebook logo Mendeley logo
          • Tweet Widget
          • Facebook Like
          • Google Plus One
          Bookmark this article

          Jump to section

          • Article
            • Abstract
            • Methods
            • Results
            • Discussion
            • Acknowledgment
            • Footnotes
            • References
          • Figures & Data
          • eLetters
          • References
          • Info & Metrics
          • PDF

          Related Articles

          • No related articles found.
          • PubMed
          • Google Scholar

          Cited By...

          • No citing articles found.
          • Google Scholar

          More in this TOC Section

          • Hematological parameters in recent and past dengue infections in Jazan Province, Saudi Arabia
          • Longitudinal analysis of foodborne disease outbreaks in Saudi Arabia
          • Psychological stress and its association with bronchial asthma in Saudi Arabia
          Show more Original Article

          Similar Articles

          Keywords

          • Ramadan
          • fasting
          • diabetes mellitus
          • IDF-DAR risk stratification
          • validity

          CONTENT

          • home

          JOURNAL

          • home

          AUTHORS

          • home
          Saudi Medical Journal

          © 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

          Powered by HighWire